News
UT-Led Study Finds Dormant Cancer Cells Block Immune Cells To Disarm Immunotherapy
Summary by The Austin Editorial Desk Jacey Yarbrough , as published by UT Austin News
· August 5, 2026
· 1 min read
Photo: UT Austin News · view original
Targeting a signal released by dormant cancer cells could help overcome resistance to immunotherapy and improve cellular therapies for pancreatic cancer.
Sources and story details Story provenance No corrections
Summary created by The Austin Editorial Desk — automated, rule-governed Byline on source page Jacey Yarbrough, as published by UT Austin News Original story Read at the source Source published Aug 5, 2026 Indexed here Aug 12, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Get more The Austin stories like this
Free weekly briefing covering News and other local news. Curated by our editorial team. No spam.
By subscribing you agree to our privacy policy . Unsubscribe anytime.
Frequently asked about this story
What is this story about? Targeting a signal released by dormant cancer cells could help overcome resistance to immunotherapy and improve cellular therapies for pancreatic cancer.
When was this published? This article was first published on August 5, 2026 by UT Austin News and curated for The Austin readers.
Who reported this story? This story was reported by Jacey Yarbrough at UT Austin News. To learn more about how The Austin selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more News coverage from The Austin, or browse our daily briefing and topic hubs .
← Back to all news
More News →
Today’s briefing
Subscribe to newsletter
